Pfizer

Pfizer Support to European and International Patient Organisations in 2009

The EFPIA Code on Relationships between the Pharmaceutical Industry and Patient Organisations came into force across Europe on 1st July 2008. Pfizer has been at the forefront of industry transparency efforts and we fully support the Code and its aims of enhancing transparency and ensuring that relationships between the pharmaceutical industry and patient organisations take place in the most open and ethical manner, in full recognition of the independence of patient organisations.


European-level patient organisations are often umbrella groups, representing the interests of their member organisations, such as national patient organisations for a particular disease or condition. They play a crucial role in debates on health policy and related issues with European policymakers and other stakeholders, providing the unique, and critical, perspective of the patient.


Financial support, such as through educational grants to support -giving full independence - an organisation’s core activities or for specific projects, only forms one aspect of our relationship with patient organisations. Increasingly, we are building relationships with patient organisations who are interested in working collaboratively with us to find new solutions to old problems. We are proud to work with many patient organisations, including those listed below, and our partnerships are open and transparent. These are 2-way relationships – we learn from each other, and our common viewpoint is that healthcare, to be effective, should be patient-centred.


The below list contains information on the support Pfizer has provided to European-level and international patient organisations in 2009. It follows the standards set out in the EFPIA code of practice governing relationships between the pharmaceutical industry and patient associations. Information to European-level and International patient organisations relevant to other countries is cross-referenced. Information on support to national patient organisations can be found via local Pfizer organisations in respective European countries.

Alzheimer Europe (AE)

Alzheimer Europe is a non-governmental organisation aimed at raising awareness of all forms of dementia by creating a common European platform through co-ordination and co-operation between Alzheimer organizations throughout Europe. Alzheimer Europe is also a source of information on all aspects of dementia.

During 2009 Pfizer UK supported the following activity: Pfizer UK gave an unrestricted grant of €50,000.00 to support them with their core activities and 2009 Annual Conference.

Pfizer UK gave an unrestricted grant of €50,000.00 to support them with their 2010 core activities and 2010 Annual Conference (paid for during 2009).

Information on this support provided to AE is also mentioned on the Pfizer UK website (www.pfizer.co.uk). Please be aware that this will differ as it follows UK transparency rules.

 

Alzheimer’s Disease International (ADI)

Alzheimer’s Disease International (ADI) is the International Federation of 77 Alzheimer associations around the world. It aims to build and strengthen Azlheimer Associations and raise awareness about dementia worldwide. The ADI is registered as a non for profit organization in the USA, but is based within the UK.

During 2009 Pfizer Inc gave an un restricted grant of $237,000.00 to support then in their core activities. Information on this support provided to ADI is also mentioned on the Pfizer UK website (www.pfizer.co.uk).

Please be aware that this will differ in format as it follows UK transparency rules.

 

Europa Donna

Europa Donna - The European Breast Cancer Coalition -is an independent non-profit organisation whose members are affiliated groups from countries across Europe. The Coalition works to raise awareness of breast cancer and to mobilise the support of European women in pressing for improved breast cancer education, appropriate screening, optimal treatment and care and increased funding for research. Europa

Donna represents the interests of European women regarding breast cancer to local and national authorities as well as to institutions of the EU. Europa Donna has 42 country members and its Head Office is located in Milan, Italy.

Pfizer International Operations provided funding of €50,000.00 to Europa Donna to support its core activities in 2009. Information on Pfizer International Organization support provided to Europa Donna is also mentioned on the Pfizer Italy website (www.pfizer.it). Please be aware that this will differ in format as it follows Italian transparency rules.


Europacolon

Europacolon raises the profile of colorectal cancer, forms patient advocacy groups throughout Europe to create a colorectal cancer community, and increases awareness of symptoms and prevention of the disease. Europacolon is committed to preventing deaths from colorectal cancer and also works towards improving the quality of life and support for all those affected by CRC in Europe.

Pfizer Inc provided funding of €5,480.00 (£5000) to Europacolon to support its core activities in 2009.
Information on this support provided to Europacolon is also mentioned on the Pfizer UK website (www.pfizer.co.uk). Please be aware that this will differ as it follows UK transparency rules.


European Brain Council (EBC)

The mission of the European Brain Council is to promote brain research in Europe and to improve the quality of life of those affected by brain diseases. The EBC is exceptional in that it brings together scientific and patient federations as equal partners.

Pfizer International Operations, as a member of the board of industrial partners, provided funding in the amount of €7,500.00 to the EBC to support its core activities in 2009.


European Cancer Patient Coalition (ECPC)

Established in 2003, The European Cancer Patient Coalition is the voice of the European cancer patient community, uniquely representing the interests of all cancer patient groups from the major to the rarer cancers.

It has been established to represent the views of cancer patients in the European healthcare debate and to provide a forum for European cancer patients to exchange information and share best practice experiences.

Pfizer International Operations, as a Sustaining Partner, provided funding in the amount of €30,000.00 to the European Cancer Patient Coalition to support its core activities in 2009 and €10,000.00 to support its Masterclass 2009. Information on this support provided to European Cancer Patient Coalition is also mentioned on Pfizer Netherlands website (www.pfizer.nl) . Please be aware that this will differ in format as it follows the Dutch transparency rules.


European Federation of Associations of Families of People with Mental Illness (EUFAMI)

EUFAMI, the European Federation of Associations of Families of People with mental illness, is the representative body for family and carer associations throughout Europe, promoting the interests and wellbeing of people with mental illness and their families and carers. It was founded in 1992 under Belgian law and is a member led federation.

Pfizer International Operations provided funding in the amount of €25,000.00 to EUFAMI to support its core activities in 2009.

Information on Pfizer International Operations support provided to EUFAMI is also mentioned on the Pfizer Belgium website (www.pfizer.be). Please be aware that this will differ in format as it follows Belgium transparency rules.


European Federation of Neurological Associations (EFNA)

The European Federation of Neurological Associations (EFNA) brings together European umbrella organisations of neurological patient advocacy groups, to work with other associations in the field of neurology, in what has been termed a ‘Partnership for Progress’. EFNA engages in activities, which contribute to the advancement of neurology and related areas with a view to improving the quality of life of people living with neurological conditions, their families and carers.

Pfizer International Operations provided funding of €25,000.00 to the European Federation of Neurological Associations to support its core activities in 2009.

Information on this support provided to EFNA is also mentioned on the Pfizer UK website (www.pfizer.co.uk). Please be aware that this will differ in format as it follows UK transparency rules.


European Institute of Women's Health (EIWH)

The European Institute of Women’s Health (EIWH), an NGO based in Dublin, was established to ensure women’s health issues are on the European policy agenda and to promote gender equity in health, research and social policies across Europe. The EIWH is working to make the health and well being of women and the family, a priority for the European Commission and EU Member States.
Pfizer International Operations provided funding in the amount of €25,000.00 to the EIWH to support its core activities in 2009.

Information on Pfizer International Operations support provided to EIWH is also mentioned on the Pfizer Ireland website (www.pfizer.ie). Please be aware that this will differ in format as it follows Irish transparency rules.


European Men's Health Forum (EMHF)

The European Men’s Health Forum (EMHF) is an independent, non-governmental, non-profit making organisation established to raise male health awareness across Europe. It aims to promote collaboration between interested individuals and organisations on the development and application of health policies, research, education and prevention programmes. EMHF provides a unique platform for non-discriminatory co-operation and information exchange within Europe and with other countries worldwide.

Pfizer International Operations provided funding in the amount of €25,000.00 to the European Men’s Health Forum to support its core activities in 2009.


European Network of Fibromyalgia Associations (ENFA)

The European Network of Fibromyalgia Associations (ENFA) is an international not for profit organisation registered in Brussels, Belgium. Their members represent 11 countries: France, Germany United Kingdom,

The Netherlands, Belgium, Spain, Portugal, Italy, Denmark, Sweden and Israel. The organisations aims are raising awareness of Fibromyalgia at the European level, promote rapid and accurate diagnosis, better access to information, public awareness and understanding, increase priority given to Fibromyalgia by policy and decision makers and by health care providers.

Pfizer International Operations provided funding of €25,000.00 to the European Network of Fibromyalgia Associations to support its core activities in 2009.

Information on Pfizer International Operations support provided to ENFA is also mentioned on the Pfizer Belgium website (www.pfizer.be). Please be aware that this will differ in format as it follows Belgium transparency rules.


European Organisation for Rare Diseases (EURORDIS)

The European Organisation for Rare Diseases, (EURORDIS www.eurordis.org), is a patient-driven alliance of patient organisations and individuals active in the field of rare diseases. EURORDIS’ mission is to build a h2 pan-European community of patient organisations and people living with rare diseases, to be their voice at the European level, and -directly or indirectly - to fight against the impact of rare diseases on their lives.

As a member of the Eurordis Round Table of Companies (ERTC) at the Emerald level, Pfizer International Operations, provided an unrestricted grant of €10,000.00 to the European Organisation for Rare Diseases (EURORDIS) to support its activities in 2009.


European Patients' Forum (EPF)

The European Patients’ Forum (EPF) is the umbrella patients’ organisation at EU level. It brings together a broad range of leading European and national patients’ organisations in different disease areas. Representing over 150 million patients, the EPF is a key interlocutor with European institutions, and promotes patients’ rights, participation and involvement in EU healthcare developments.

Pfizer International Operations provided co-sponsorship in the amount of €50,000.00 to the Value + Final Conference – Sweden, December 2009 and an unrestricted grant to support policy activities during the Swedish Presidency in the amount of €40,000.


GAMIAN Europe

GAMIAN-Europe (Global Alliance of Mental Illness Advocacy Networks – Europe) is a pan-European patient driven federation of organisations across Europe assisting people affected by mental illness. Its main objectives are: advocacy, information and education, anti-stigma and discrimination, patients’ rights, co-operation, partnerships and capacity building.

Pfizer International Operations provided funding in the amount of €25,000.00 to GAMIAN-Europe to support its core activities in 2009.

Information on this support provided to GAMIAN – Europe is also mentioned on the Pfizer Belgium website (www.pfizer.be). Please be aware that this will differ in format as it follows Belgium transparency rules.
International Alliance of Patient Organisations (IAPO)
IAPO is a unique global alliance representing patients of all nationalities across all disease areas and promoting patient – centered healthcare around the world.

Members of IAPO are patients’ organizations working at the international, regional, national and local levels to represent and support patients, their families and carers. A patient is a person with any chronic disease, illness, syndrome, impairment or disability.

In 2009 Pfizer Inc supported IAPO in the following activities:

  1. Travel for Patient Advocates to IAPO Workshop: Working Effectively with the WHO (MAY) - $3890.68
  2. In kind support [World Health Advocacy] Accommodations for Patient Advocates to IAPO Workshop: Working Effectively with the WHO (May) $3339.16
  3. In kind support [Retina Hong Kong – K.P. Tsang] travel for workshops in Philippines (August) $359.71
  4. Travel for 12 patient representatives to attend Latin America Regional Workshop (October) $ 25698.34
  5. Health Care Industry Partners: Gold Partnership (December) $50,000.00

Information on this support provided to IAPO is also mentioned on the Pfizer Netherlands website (www.pfizer.nl). Please be aware that this will differ in format as it follows Dutch transparency rules.
International Diabetes Federation - Europe Region (IDF-Europe)
As the only European Advocate for people with diabetes and their healthcare providers, the International

Diabetes Federation European Region works together with its member associations and other diabetes stakeholders to enhance the lives of people with diabetes. Many of IDF member associations are made up of people with diabetes and health care professionals. The mission of the International Diabetes Federation is to promote diabetes care, prevention and a cure worldwide.

Pfizer International Operations, as a Corporate Partner, provided funding in the amount of €25,000.00 to IDF – Europe to support its core activities in 2009.


Sarcoma Patients EuroNet (SPAEN)

Sarcoma Patients EuroNet e.V./Assoc. (SPAEN) SPAEN is a collaborative association that brings together European advocacy and support groups working together with patients who have some of the rarest cancers.

Acting in partnership with clinical experts, scientific researchers and other stakeholders SPAEN is working to improve the treatment and care of sarcoma patients in Europe through improving information and support, and by increasing the awareness of sarcoma in the medical landscape and the public.

Pfizer International Operations provided funding of €25,000.00 to the Sarcoma Patients EuroNet (SPAEN) to support its core activities in 2009.


Wyeth 2009 Funding

Wyeth is now a part of Pfizer Inc. The merger of local Wyeth and Pfizer entities may be pending in various jurisdictions and is subject to completion of various local legal and regulatory obligations. To learn more, please visit www.pfizer.com.